These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10764969

  • 1. Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin.
    Wong SS, Ng TK, Yam WC, Tsang DN, Woo PC, Fung SK, Yuen KY.
    Diagn Microbiol Infect Dis; 2000 Apr; 36(4):261-8. PubMed ID: 10764969
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
    Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K.
    J Antimicrob Chemother; 1998 Aug; 42(2):199-209. PubMed ID: 9738837
    [Abstract] [Full Text] [Related]

  • 4. Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in Staphylococcus aureus.
    Nishi H, Komatsuzawa H, Yamada S, Fujiwara T, Ohara M, Ohta K, Sugiyama M, Ishikawa T, Sugai M.
    Microbiol Immunol; 2003 Aug; 47(12):927-35. PubMed ID: 14695442
    [Abstract] [Full Text] [Related]

  • 5. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL, Fasching CE, Peterson LR.
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [Abstract] [Full Text] [Related]

  • 6. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR.
    N Engl J Med; 1999 Feb 18; 340(7):493-501. PubMed ID: 10021469
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 Oct 11; 51(40):902. PubMed ID: 12418544
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Absence of mutation in the region (nt. 710-1010) of pbp4 gene in clinical isolates of Staphylococcus aureus with low-level teicoplanin resistance.
    Park Y, Oh EJ, Lee SO, Kim BK.
    Diagn Microbiol Infect Dis; 2001 Apr 11; 39(4):271-3. PubMed ID: 11404074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF, Sachdeva M, Kennedy S.
    J Infect Dis; 1990 Sep 11; 162(3):705-10. PubMed ID: 2387996
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
    Piddock LJ, Traynor EA, Griggs DJ.
    Eur J Clin Microbiol Infect Dis; 1992 Apr 11; 11(4):364-71. PubMed ID: 1396760
    [Abstract] [Full Text] [Related]

  • 17. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL, Cheron M, Benabid D, Leneveu M, Boisivon A, Association of Hospital Bacteriologists, Virologists and Hygiene Professionals.
    Clin Microbiol Infect; 2004 May 11; 10(5):448-51. PubMed ID: 15113324
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Terminology of Staphylococcus aureus strains showing decreased susceptibility to methicillin.
    Smith JM.
    J Antimicrob Chemother; 1992 Feb 11; 29(2):219-21. PubMed ID: 1506337
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.